author-photo

Yuxian Bai

Harbin Medical University

204

Papers

2989

Citations

Citation Trend

Filter By

Papers (146) Sort By

Journal Conference Others

ESCORT-1st: A randomized, double-blind, placebo-controlled, phase 3 trial of camrelizumab plus chemotherapy versus chemotherapy in patients with untreated advanced or metastatic esophageal squamous cell carcinoma (ESCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Research on Virtual Reality 3D Exhibition Hall based on the Smart Campus of Geely University

2021
Show All
- Source
- Cite
- Save
Citations (0)
Subgroup analysis by prior anti-VEGF or anti-EGFR target therapy in FRESCO, a randomized, double-blind, Phase III tri1al.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (0)
[Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)].

2021 Chinese journal of oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PATH01.03 Mutational Landscape and Prognosis Prediction for Immune Checkpoint Blockades of DNA Damage Response Pathways in Non-Small Cell Lung Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P75.07 Association of FGFR4 Mutation With Immunotherapy Outcomes in Patients With Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacokinetic study of lenvatinib in Chinese patients with solid tumors.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (1)
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma.

2021 Cancer biology and medicine
Show All
- Source
- Cite
- Save
Citations (1)
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)